Close Menu

NEW YORK (GenomeWeb) – In a lawsuit filed with the Superior Court of the State of California late Wednesday, Agilent Technologies has claimed that Twist Bioscience, its Founder and CEO Emily LeProust, and 20 other unnamed defendants, have stolen a certain genomics technology from Agilent.

"Emily LeProust is a scientist who, in a premeditated plan, stole industry-leading genomics technology from her longtime employer, Agilent Technologies, to start her own competitive company, Twist Bioscience," the complaint reads.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.

By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.

NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.

In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.